Drugs

Page 10 of 29

Pascal Soriot, chief executive officer of AstraZeneca Plc.
Retail

AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030

By Ashleigh Furlong and Bloomberg
May 21, 2024
Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift
Health

Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift

By The Associated Press and Lindsay Whitehurst
May 16, 2024
Man Fills Bong With Cannabis Leaves
Companies

Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame

By
May 15, 2024
What Medicare beneficiaries need to know about generic medications
Aging Well

What Medicare beneficiaries need to know about generic medications

By
May 15, 2024
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
Tech

Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology

By
May 8, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Retail

Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition

By Naomi Kresge and Bloomberg
May 2, 2024
Novo Nordisk CEO Lars Fruergaard Jorgensen Interview
Retail

Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark

By Sanne Wass, Naomi Kresge and Bloomberg
May 1, 2024
Marijuana
Politics

Biden’s DEA to reclassify marijuana in historic shift that still doesn’t decriminalize it, sources say

By Zeke Miller, Joshua Goodman, Jim Mustian, Lindsay Whitehurst and The Associated Press
April 30, 2024
Gavin Newsom
Politics

Frustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses

By Adam Beam and The Associated Press
April 29, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters

AI for drug discovery draws a $1 billion launch—and a lot of hope

By
April 25, 2024
Pascal Soriot, CEO of AstraZeneca. Under Soriot, Astra has invested heavily in cancer drugs.
Retail

AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs

By Ashleigh Furlong and Bloomberg
April 25, 2024
Felipe de Jesus Gallo
Finance

Mexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia

By
April 24, 2024
Researchers at SUNY Upstate Medical University found that nonmedical cannabis use—regardless of how or how often it was consumed—lowered a person’s odds of subjective cognitive decline by 96%.
Mind

Recreational cannabis use may lower your risk of cognitive decline, study says

By
April 19, 2024
The Waldos
Lifestyle

‘It’s a phenomenon’: How 4/20 grew organically from a group of Northern California high schoolers into marijuana’s holiday

By Gene Johnson and The Associated Press
April 19, 2024
A pharmacist assists a customer with medical marijuana.
Newsletters

Millions of Americans have used medical marijuana. Is it covered by their FSAs?

By
April 19, 2024

Most Popular